Authors:
ARISTEGUI J
DALRE R
GARROTE E
GONZALEZ A
ARRATE JP
PEREZ A
Citation: J. Aristegui et al., ASSESSMENT OF THE IMMUNOGENICITY AND REACTOGENICITY OF A QUADRIVALENTDIPHTHERIA, TETANUS, ACELLULAR PERTUSSIS AND HEPATITIS-B (DTPA-HBV) VACCINE ADMINISTERED IN A SINGLE INJECTION WITH HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINE, TO INFANTS AT 2, 4 AND 6 MONTHS OF AGE, Vaccine, 16(20), 1998, pp. 1976-1981
Authors:
GIL A
GONZALEZ A
DALRE R
ORTEGA P
DOMINGUEZ V
Citation: A. Gil et al., PREVALENCE OF ANTIBODIES AGAINST VARICELLA-ZOSTER, HERPES-SIMPLEX (TYPE-1 AND TYPE-2), HEPATITIS-B AND HEPATITIS-A VIRUSES AMONG SPANISH ADOLESCENTS, The Journal of infection, 36(1), 1998, pp. 53-56
Authors:
BADIA X
GARCIALOSA M
DALRE R
CARBALLIDO J
SERRA M
Citation: X. Badia et al., VALIDATION OF A HARMONIZED SPANISH VERSION OF THE IPSS - EVIDENCE OF EQUIVALENCE WITH THE ORIGINAL AMERICAN SCALE, Urology, 52(4), 1998, pp. 614-620
Authors:
PRIETO J
AGUILAR L
GIMENEZ MJ
TORO D
GOMEZLUS ML
DALRE R
BALCABAO IP
Citation: J. Prieto et al., IN-VITRO ACTIVITIES OF CO-AMOXICLAV AT CONCENTRATIONS ACHIEVED IN HUMAN SERUM AGAINST THE RESISTANT SUBPOPULATION OF HETERORESISTANT STAPHYLOCOCCUS-AUREUS - A CONTROLLED-STUDY WITH VANCOMYCIN, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1574-1577
Citation: R. Dalre et al., EFFICIENCY OF INVESTIGATORS IN RECRUITMEN T OF PATIENTS FOR CLINICAL-TRIALS - A CASE-REPORT OF A MULTINATIONAL STUDY, Medicina Clinica, 110(14), 1998, pp. 521-523
Authors:
GIL A
GONZALEZ A
DALRE R
DOMINGUEZ V
ASTASIO P
AGUILAR L
Citation: A. Gil et al., DETECTION OF ANTIBODIES AGAINST HEPATITIS-A IN BLOOD SPOTS DRIED ON FILTER-PAPER - IS THIS A RELIABLE METHOD FOR EPIDEMIOLOGIC STUDIES, Epidemiology and infection, 118(2), 1997, pp. 189-191
Authors:
MARTIN M
AGUILAR L
BALCABAO IP
GOMEZLUS ML
DALRE R
PRIETO J
Citation: M. Martin et al., IN-VITRO PHARMACODYNAMIC SIMULATION OF CLAVULANIC ACID CONCENTRATIONS- EFFECT ON STAPHYLOCOCCUS-AUREUS AND HAEMOPHILUS-INFLUENZAE BETA-LACTAMASE ACTIVITY, Journal of antimicrobial chemotherapy, 39(2), 1997, pp. 290-292
Citation: X. Badia et al., 10-LANGUAGE TRANSLATION AND HARMONIZATION OF THE INTERNATIONAL PROSTATE SYMPTOM SCORE - DEVELOPING A METHODOLOGY FOR MULTINATIONAL CLINICAL-TRIALS, European urology, 31(2), 1997, pp. 129-140
Authors:
DIEZDELGADO J
DALRE R
LLORENTE M
GONZALEZ A
LOPEZ J
Citation: J. Diezdelgado et al., HEPATITIS-B COMPONENT DOES NOT INTERFERE WITH THE IMMUNE-RESPONSE TO DIPHTHERIA, TETANUS AND WHOLE-CELL BORDETELLA-PERTUSSIS COMPONENTS OF A QUADRIVALENT (DTPW-HB) VACCINE - A CONTROLLED TRIAL IN HEALTHY INFANTS, Vaccine, 15(12-13), 1997, pp. 1418-1422
Authors:
AGUILAR L
MARTIN M
BALCABAO IP
GOMEZLUS ML
DALRE R
PRIETO J
Citation: L. Aguilar et al., IN-VITRO ASSESSMENT OF THE EFFECT OF CLAVULANIC ACID AT CONCENTRATIONS ACHIEVED IN HUMAN SERUM ON THE BACTERICIDAL ACTIVITY OF AMOXICILLIN AT PHYSIOLOGICAL CONCENTRATIONS AGAINST STAPHYLOCOCCUS-AUREUS - IMPLICATIONS FOR DOSAGE REGIMENS, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1403-1405
Authors:
AGUILAR L
GIMENEZ MJ
COSTA J
DALRE R
PRIETO J
Citation: L. Aguilar et al., SUSPICION OF QUINOLONE ACTIVE METABOLITE FOLLOWING DISCREPANCY BETWEEN PREDICTED AND EXPERIMENTAL URINE BACTERICIDAL ACTIVITIES, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 927-930
Authors:
BANOS JG
ANDREU JL
GAYARRE AL
ARANBURU JM
OLAIZOLA JMG
ANGULO EU
SANDOVAL AA
GALDO F
BELZUNEGUI J
PEDROSA MF
GONZALEZ C
PINEDA MB
MOLA EM
DEAYALA CP
SECALL EC
BUSQUIER MP
MORENO CC
ESCOFET DR
GUIXERES EC
VALERO JVF
NUNEZCORNEJO C
DALRE R
GARCIALOSA M
LOPEZ AG
GOMEZ JP
CARRERA JQ
PEREZ SG
ESTEVEVIVES J
PERALTA MF
UBEDA EG
SANILDEFONSO MM
Citation: Jg. Banos et al., EFFICACY AND SAFETY OF NABUMETONE IN THE TREATMENT OF KNEE OSTEOARTHRITIS - A COMPARATIVE CLINICAL-TRIAL VERSUS ACECLOFENAC, Medicina Clinica, 109(4), 1997, pp. 130-134
Authors:
BALLESTEROS J
DALRE R
GONZALEZ A
DELROMERO J
Citation: J. Ballesteros et al., ARE HOMOSEXUAL MALES A RISK GROUP FOR HEPATITIS-A INFECTION IN INTERMEDIATE ENDEMICITY AREAS, Epidemiology and infection, 117(1), 1996, pp. 145-148
Citation: L. Aguilar et al., PNEUMOCOCCAL BACTEREMIC PNEUMONIA - CAN AMOXICILLIN DECREASE STREPTOCOCCUS-PNEUMONIAE VIRULENCE IN A CLINICALLY RELEVANT DEGREE, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 103-103
Authors:
GIMENEZ MJ
AGUILAR L
COSTA J
DALRE R
VEDIA C
SALVA P
Citation: Mj. Gimenez et al., ESTIMATED VERSUS EXPERIMENTAL URINARY ANTIBACTERIAL ACTIVITY - IMPLICATIONS FOR DOSAGE, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 104-104
Citation: J. Espada et al., PATIENT RECRUITMENT IN CLINICAL-TRIALS - THE PERFORMANCE AND EFFICIENCY OF CENTERS PARTICIPATING IN A MULTICENTER TRIAL, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 110-110
Authors:
BRUGUERA M
BAYAS JM
VILELLA A
TURAL C
GONZALEZ A
VIDAL J
DALRE R
SALLERAS L
Citation: M. Bruguera et al., IMMUNOGENICITY AND REACTOGENICITY OF A COMBINED HEPATITIS-A AND HEPATITIS-B VACCINE IN YOUNG-ADULTS, Vaccine, 14(15), 1996, pp. 1407-1411
Citation: A. Gil et al., INTERFERENCE ASSESSMENT OF YELLOW-FEVER VACCINE WITH THE IMMUNE-RESPONSE TO A SINGLE-DOSE INACTIVATED HEPATITIS-A VACCINE (1440-ELU) - A CONTROLLED-STUDY IN ADULTS, Vaccine, 14(11), 1996, pp. 1028-1030
Authors:
DELRIO G
DALET F
AGUILAR L
CAFFARATTI J
DALRE R
Citation: G. Delrio et al., SINGLE-DOSE RUFLOXACIN VERSUS 3-DAY NORFLOXACIN TREATMENT OF UNCOMPLICATED CYSTITIS - CLINICAL-EVALUATION AND PHARMACODYNAMIC CONSIDERATIONS, Antimicrobial agents and chemotherapy, 40(2), 1996, pp. 408-412
Authors:
BALCABAO IP
AGUILAR L
MARTIN M
GARCIA Y
DALRE R
PRIETO J
Citation: Ip. Balcabao et al., ACTIVITIES AGAINST STREPTOCOCCUS-PNEUMONIAE OF AMOXICILLIN AND CEFOTAXIME AT PHYSIOLOGICAL CONCENTRATIONS - IN-VITRO PHARMACODYNAMIC SIMULATION, Antimicrobial agents and chemotherapy, 40(12), 1996, pp. 2904-2906
Authors:
AGUILAR L
BALCABAO IP
SALVA P
MARTIN M
COSTA J
PRIETO J
DALRE R
Citation: L. Aguilar et al., EX-VIVO ANTIBACTERIAL PROPERTIES OF RUFLOXACIN COMPARED WITH THOSE OFNORFLOXACIN IN A STUDY WITH HEALTHY-VOLUNTEERS, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 17-21